Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08VSV
|
|||
Drug Name |
US10150740, Example 4
|
|||
Synonyms |
SCHEMBL18426560; US10150740, Example 4; BDBM307508
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H20N2O5
|
|||
Canonical SMILES |
CC(C)N1CC2=CC(=C(C=C2C3=CC(=O)C(=CN31)C(=O)O)OC)OC
|
|||
InChI |
1S/C18H20N2O5/c1-10(2)19-8-11-5-16(24-3)17(25-4)6-12(11)14-7-15(21)13(18(22)23)9-20(14)19/h5-7,9-10H,8H2,1-4H3,(H,22,23)
|
|||
InChIKey |
PURJTKDWCZADSM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Hepatitis C virus Core protein messenger RNA (HCV Core mRNA) | Target Info | Inhibitor | [1] |
Target's Patent Info | Hepatitis C virus Core protein messenger RNA (HCV Core mRNA) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | 6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection. US10150740. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.